Childhood B-cell precursor acute lymphoblastic leukemia (BCP ALL) is generally a clonal disease in which the number of IGH rearrangements per cell does not exceed the number of the IGH alleles on chromosome 14. Consequently, monoclonal high hyperdiploid (HeH) cases with a trisomy 14 can harbor three rearrangements, a pattern that otherwise may be misinterpreted to be oligoclonal. Oligoclonal IGH rearrangements, on the other hand, may be instable at relapse and should therefore not be used for minimal residual disease analysis. We thus investigated the association between IGH allele copy numbers and the IGH rearrangement patterns in 90 HeH BCP ALL with either two (13%) or three copies (87%) of chromosome 14. HeH cases (44%) had an oligoclonal IGH rearrangement pattern, but true oligoclonalityFafter correction for the respective copy number of IGH allelesFwas only 16%. Monoclonal and oligoclonal HeH cases had predominantly V H to preexisting DJ H recombinations, a finding that contrasts with oligoclonal cases of other major genetic BCP ALL subgroups in which V H replacements prevail. We conclude that for the precise assessment and correct interpretation of clonality patterns in BCP ALL, the IGH allele copy number has to be taken into consideration.
Introduction
A high hyperdiploid (HeH) karyotype with 51-68 chromosomes is found in about one-third of childhood B-cell precursor acute lymphoblastic leukemia (BCP ALL) and is generally associated with a good prognosis. Nevertheless, approximately 20% of cases experience a relapse. 1 The likelihood of relapse was found to correlate with the presence of specific trisomies, whose predictive value also depended on the respective treatment protocol. [2] [3] [4] The PCR-based determination of minimal residual disease (MRD) has evolved as the most relevant parameter for treatment stratification and is nowadays used worldwide. 1 Leukemia-associated immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements provide unique clone-specific molecular markers for MRD analysis. Given their presence in the vast majority of BCP ALL and favorable sensitivity, Ig heavy chain (IGH) gene rearrangements are the most frequently used targets for the detection of MRD. 5 However, the encountered high frequency of oligoclonal IGH rearrangement patterns at diagnosis together with the instability of the individual rearrangements at relapse has questioned its use as a clonal marker for MRD detection. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] IGH genes are rearranged in an ordered fashion during lymphoid development starting with a DJ H rearrangement on both alleles. Then, a V H segment is joined to one of the DJ H rearrangements. If functional, the Igm protein is expressed in the cytoplasm and the other allele is excluded from further recombination. Otherwise, the same process takes place at the second allele to produce a functional Igm protein. B precursor cells that do not reach this goal undergo apoptosis. 16 A similar recombination process is probably operative in ALL with the exception that cells do not need a functional receptor to survive. In addition, IGH rearrangements might be secondarily modified in the preleukemic/leukemic cell owing to the persistent activity of the recombination machinery.
Chromosome 14, which contains the IGH locus, is frequently trisomic and occasionally even tetrasomic in HeH BCP ALL leukemias. 4 Accordingly, the number of IGH rearrangements per leukemia may be higher than in cases with disomy 14. Because only one rearrangement takes place per IGH allele per cell and clonal progeny, the maximum number of individual IGH rearrangements of such clones depends on the copy numbers of IGH alleles and therefore indirectly also on the copy numbers of chromosome 14. 4 A clone with disomy 14 can have a maximum of two unique rearrangements, whereas a clone with trisomy 14 could harbor either a maximum of three unique or two unique rearrangements together with a third that may share particular sequences with the one or the other. 17 The latter would derive from a duplicated, primarily rearranged IGH gene that continues to rearrange after the nondisjunction event. Duplicated IGH rearrangements that do not undergo further modifications cannot be discriminated.
Although several studies have evaluated and compared the various types of IGH rearrangements in the major genetic BCP ALL subgroups already, none of them has so far taken into consideration the potential effects of IGH allele copy numbers in this context. [17] [18] [19] [20] We therefore determined the IGH rearrangements in 130 children with HeH BCP ALL (90 consecutively recruited and 40 selected cases) and correlated their individual sequence and clonality pattern with their respective IGH allele and/or chromosome 14 copy numbers. Our aim was to determine to which extent these IGH rearrangement patterns may be used to delineate monoclonal cases with a trisomy 14 from oligoclonal ones with a disomy 14 and to discuss the implications of our findings for leukemia biology and MRD analysis.
Materials and methods

Patient selection
Ninety cases with an HeH karyotype were recruited from a complete series of 384 BCP ALL patients, which were enrolled in the Austrian-BFM 2000 study. Nine cases with a t(1;19), t(4;11) or t(9;22) were excluded. The remaining BCP ALL had either a t(12;21) (n ¼ 105) or belonged to the group of 'others' that include not further genetically discriminated cases (n ¼ 180) and served as controls. The Austrian cohort was used for the assessment of overall frequencies, while relative frequencies were calculated from an enlarged data set including additional HeH cases (n ¼ 40) from the two consecutive Dutch Childhood Leukemia Study Group ALL-8 or ALL-9 treatment protocols. The recruitment of additional cases was necessary to increase the number of small subgroups.
ALL diagnosis was based on standard morphological, cytochemical and immunological criteria. Informed consent was granted in accordance with the Declaration of Helsinki. Local hospital and research ethics committee approval was obtained at each participating center.
Cytogenetic and fluorescence in situ hybridization analyses
Cytogenetic analyses of banded bone marrow (BM) mononuclear cell preparations were performed according to standard procedures. IGH allele copy numbers were determined with interphase fluorescence in situ hybridization (FISH) and an LSI IGH Dual Color, Break Apart Rearrangement Probe (Vysis; Downers Grove, IL, USA) according to the manufacturer's recommendation on methanol/acetic-acid-fixed cell samples that had been stored at À20 1C. At least 200 nuclei per sample were screened. A sample was considered to contain a clone with three IGH alleles, if metaphases contained three chromosomes 14 and/or the respective trisomic IGH signal pattern was identified in at least 20% of the interphase nuclei.
Identification of PCR targets at diagnosis
DNA was extracted from BM mononuclear cell that contained more than 90% of blasts and analyzed for incomplete (DJ) and complete (VDJ) IGH rearrangements according to standardized protocols. PCR amplification, heteroduplex analysis and sequencing were performed as described previously. 21, 22 The involved segments of IGH rearrangements were identified by comparison with published germ-line sequences using Blast (www.ncbi.nlm.nih.gov/BLAST), IgBlast (www.ncbi.nlm.nih. gov/igblast), IMGT (http://www.imgt.cines.fr) and VBASE/DNA-PLOT directory of human Ig genes (http://www.mrc-cpe. cam.ac.uk).
Southern blot analysis of IGH gene configurations
DNA was digested with BgIII and blotted to nylon membranes as described previously. 17 IGH rearrangements were studied by using a mixture of fluorescein isothiocyanate-labeled oligonucleotides (hybridizing with sequences just downstream of the IGHJ6 gene segment) followed by detection with the Chemiluminescent System for Nucleic Acid Blotting (Dako, Carpinteria, CA, USA).
Definition of monoclonality and oligoclonality
A sample was assumed to be monoclonal if the number of IGH rearrangements detected by PCR was equal or less than the IGH or chromosome 14 copy numbers (exemplified in Table 1 ), irrespective of the intensity of the PCR bands. Although weak bands are likely to represent minor subclones, their intensity was not taken into account because consensus primers were used for the detection of these rearrangements, which precluded the quantification of PCR products. A sample was considered to be oligoclonal if the number of IGH rearrangements exceeded the copy number of IGH alleles or chromosomes 14. Moreover, the presence of two rearrangements with partial sequence homology was taken as an indication of subclone formation in all cases without an extra chromosome 14. The presence of more than two related rearrangements, however, was considered to always represent oligoclonal populations. This principle of classification was used for the PCR-based study of clonotypic rearrangements presuming that no irregular rearrangement or germ-line configuration was present in addition to the detected rearrangements.
Southern blot (SB) data were evaluated based on the percentage of leukemic cells and the number and intensities of the various bands. If two bands with equal intensity were detected in patients with a disomy 14, a monoclonal configuration was assumed. In patients with trisomy 14, the presence of three equally intense bands was considered to represent a monoclonal population. If additional (weaker) bands were found, the sample was considered to be oligoclonal.
Statistical analysis w
2 , Pearson's exact or Fisher's exact test was used to compare frequencies of gene rearrangements between groups. The SAS package (SAS Institute, Cary, NC, USA) was used for these analyses. Wilcoxon two-sample test was used to compare the age of different subgroups. Clonality agreement between two methods (PCR versus SB) was assessed by the k value. Table 1 Typical examples of IGH rearrangements in HeH leukemias 
Results
Frequency of HeH patients with disomy or trisomy 14
The frequency of HeH leukemias within the Austrian BCP ALL cohort was 23% (90 out of 384 patients). Of these 90 HeH leukemias, 68 (76%) had either three (n ¼ 64) or four (n ¼ 4) copies and only 22 (24%) had two copies of chromosome 14.
Owing to the small number of cases in the latter group, additional cases were included from the Dutch study group (n ¼ 40; 16 cases with trisomy 14 and 24 cases with disomy 14). To exclude the possibility that an additional copy of chromosome 14 had been missed in cases with disomy 14 by cytogenetic analysis, FISH was performed and revealed a trisomic clone in 18 of the 46 cases. Thus, the overall number of HeH cases with disomy 14 was reduced to 28 and the unbiased frequency, assessed in the unselected Austrian cohort, to 13% (n ¼ 12/90). Leukemias with a trisomy 14 and those with a disomy 14 are referred to as group I and II, respectively. The four cases with a tetrasomy 14 were incorporated in the group of trisomy 14, but their clonality pattern was assessed separately. All four cases appeared to be monoclonal as they had only up to three rearrangements including one case with two rearrangements and a partial sequence homology.
Frequency and type of IGH rearrangements
As shown in Table 2 , at least one IGH rearrangement was identified in about 95% of the cases. In line with earlier reports, 17,18 a relative high frequency of cases with incomplete DJ H rearrangements was observed comprising 46 and 29% of groups I and II, respectively. In both groups, 10% of patients had a DJ H rearrangement as the only type of IGH recombination. Frequencies of complete VDJ H rearrangement were similar in both subgroups (approximately 85%) while those with a VDJ H rearrangement as the only type of rearrangements was less frequent in group I than in group II (47 versus 64%). However, none of these differences reached statistical significance.
Clonality
Monoclonal and oligoclonal populations were defined as described in detail in the Material and method section. Notably, the frequency of oligoclonality differed between groups with trisomy and disomy 14 and was significantly lower in group I than in group II (Table 2 ). In about half of the cases, oligoclonality was defined by the concurrence of sequence homology and a higher number of IGH rearrangements than that of chromosome 14 copies (Table 3) .
Moreover, oligoclonal cases revealed subtle differences in the frequencies of types of rearrangements compared to their clonal counterparts (Figure 1 ). Oligoclonal cases in both groups showed a significant tendency toward a more 'immature' pattern of rearrangements as defined by a higher frequency of incomplete rearrangements and a corresponding lower frequency of complete rearrangements as the only type of recombination (w 2 , P ¼ 0.004 and 0.007, respectively).
Features of IGH rearrangements and their relation to clonality
In group I, the frequency of related rearrangements was 29% (Table 2) . Two-thirds of them were detected in monoclonalappearing leukemias, while the remaining third was found in oligoclonal patients, in which related rearrangements accounted for 85%. As expected from the high frequency of incomplete DJ H rearrangements in HeH leukemias, related rearrangements reflected a V H or D H to DJ H join in the majority of cases. V H or D H replacements, on the other hand, were rare. The latter type of ongoing recombination occurred slightly more frequently in oligoclonal cases (Table 4) . As group II leukemias may have a maximum of two unique sequences in a monoclonal population, the presence of more than two (n ¼ 9) and/or related (n ¼ 6) rearrangements accounted for oligoclonality in 10 of the 28 cases (36%) ( Table 2 ).
Comparison of monoclonality or oligoclonality defined by PCR and Southern blot analysis
For evaluation of IGH gene configuration, SB data were obtained from a representative group of HeH leukemias (n ¼ 82). Sixty and twenty-two cases were in group I and II, respectively. The overall accordance rate between the two methods for classifying leukemias as monoclonal or oligoclonal showed a moderate agreement (k ¼ 0.56). When analyzed according to subgroups, the frequency of PCR oligoclonality was similar to that of SB in both groups confirming the higher frequency of oligoclonality in group II. (Oligoclonality in group I: PCR and SB, 18 and 25%, respectively; in group II: 41% with both methods.)
Patterns of IGH rearrangements according to the genetic subtype of BCP ALL
To delineate potential differences between different genetic subgroups of BCP ALL, the frequency and features of seemingly oligoclonal IGH rearrangements of HeH cases were compared to those from the two other major subgroups of BCP ALL, the TEL-AML1 positive leukemias and the group of 'others', not further genetically discriminated BCP ALLs. For this purpose, we used 105 TEL-AML1 positive and 180 'other' leukemias, which were enrolled in Austrian protocol A-BFM 2000 at the same time and analyzed in the same way as the 90 HeH cases. As shown in Table 3 , the frequency of oligoclonal-appearing patterns significantly differed between HeH and the two other subtypes (Pearson's exact test, P ¼ 0.03), while the 'true' oligoclonality of 16% in HeH (that is, number and types of rearrangements corrected for the actual copy number of chromosome 14) resembled the frequency of oligoclonality in the other leukemic subgroups (Pearson's exact test, P ¼ 0.13). The majority of oligoclonal-appearing cases were defined by the presence of more than two rearrangements ranging from 80% in HeH leukemias to 100% in the 'others' (Fisher's exact test, P ¼ 0.01), whereas related rearrangements were more frequently detected in HeH than in the other subgroups of BCP ALLs. A combination of these two features was found in less than 50% in all subgroups.
Moreover, we asked whether the type of secondary rearrangements, which lead to the diversification of two homologous sequences in trisomy 14, but to subclone formation in disomy 14 cases, differs between the three genetic subtypes of ALL (Table 4) . For this analysis, the complete cohort of 130 HeH cases was used to increase the oligoclonal population. As mentioned before, the majority of monoclonal HeH cases revealed a V H (or D H ) to DJ H recombination and, only rarely, a The frequency of 'true' oligoclonality is 16% (n ¼ 14/90) and was determined by individually correlating the number and patterns of IGH rearrangements with the respective copy number of chromosomes 14 and/or IGH alleles. 
Related rearrangements % (n) 18 (19) 74 ( IGH rearrangements in hyperdiploid B precursor ALL E Csinady et al V H (or D H ) replacement. The latter type of secondary rearrangements was slightly more common in the oligoclonalappearing HeH cases. In contrast, TEL-AML1 positive leukemias as well as the subgroup of 'other' BCP ALL had an inverse ratio between V H to DJ H and V H replacements compared to the HeH. The difference between HeH and TEL-AML1 positive cases and 'others' was significant (Fisher's exact test, P ¼ 0.03).
Discussion
We evaluated the frequency and characteristics of IGH rearrangements in HeH BCP ALL and related them with the case-specific IGH alleles or, as a surrogate parameter, chromosome 14 copy numbers. Even though the majority of cases had an extra copy of chromosome 14, there was a small but distinct subgroup comprising 13% of HeH cases with disomy 14. More than two IGH rearrangements and/or related rearrangements were found in 44% of the same HeH cohort with an overall proportion of 16% oligoclonality after correction for the actual copy number of chromosome 14. Of note, leukemias with only two copies of chromosome 14 revealed a higher frequency of apparent oligoclonality compared to those with three or four copies of chromosome 14 (36 versus 13%). Monoclonal HeH leukemias with trisomy 14 could not be distinguished from their oligoclonal counterparts based on numbers of IGH rearrangements per case and the types of secondary rearrangements. Considering the characteristics of the oligoclonal pattern (that is, the number of IGH rearrangements exceeding those of chromosome 14 copies and/or related rearrangements as well as the type of secondary rearrangements) in HeH leukemias and comparing them with oligoclonal cases of the two other major subgroups of BCP ALL, the TEL-AML1 positive leukemias and 'others', it became evident that the patterns had shifted from a primarily V H (D H ) to DJ H recombination in the former toward V H replacements in the latter two groups. Furthermore, IGH clonality was compared between PCR and SB analysis in a representative cohort of cases. Although overall frequencies of monoclonal and oligoclonal cases were highly concordant by both methods in group I and group II (about 20 and 40%, respectively), the overlapping populations showed only moderate agreement, mainly because of method-related differences. The high frequency of IGH rearrangements with a significant proportion of incomplete DJ H rearrangements in HeH leukemias concords with published data derived from a screening for incomplete IGH rearrangements in BCP ALL. 17 They confirm, together with a high frequency of related IGH rearrangements and of three or more rearrangements in almost 45% of cases, the notion that the nondisjunction of chromosomes leading to an HeH karyotype affects a cell at the beginning of IGH recombination. 23, 24 In line with this notion, the other half of HeH leukemias with no more than two IGH rearrangements supposedly have duplicated a chromosome 14 with a preexisting (V H )DJ H rearrangement that is not modified anymore thereafter. Additional features from SB also fit in this concept, as the vast majority of cases lack IGH germ-line configuration or deletions. We thus propose a model for the timing of somatic recombination of IGH genes and the nondisjunction of chromosomes 14, which suggests that cells usually already have a DJ H rearrangement before the nondisjunction event, which presumably occurs already in utero. [25] [26] [27] [28] Even though the immunogenetic data from this study strongly suggest that HeH forms are arrested in a more immature stage of differentiation than other genetic subgroups, 16 this fact is not at all reflected on the immunophenotypic level, since pre-B and common ALL immunophenotypes are equally frequent in the three major investigated BCP ALL categories (data not shown).
It was suggested previously that the type of ongoing recombination provides some information on the status of IGH gene configuration at the time of cell transformation. 29 Thus, the high frequency of V H (or D H ) to DJ H joins in HeH leukemias concords with their immature immunogenotype, 11, 29 whereas TEL-AML1 positive cases more frequently had V H replacements as secondary rearrangements, which implies that the translocation had occurred in a more advanced cell. This assumption is supported by earlier observations on V H replacements at relapse occasions. 9 On the other hand, TEL-AML1 positive relapses can carry completely new and unique IGH rearrangements. The emergence of such clones can only be explained if the IGH genes were still in a germ-line configuration at the time of leukemic transformation. 9 The rather mature immunogenotype of TEL-AML1 positive leukemias with rare incomplete rearrangements, 18 which is most likely caused by high RAG activity and an ensuing high rate of recombination, 30, 31 contrasts with the immature immunogenotype of HeH cases. Similarly, the cases compiled in the heterogeneous group of the remaining BCP ALL seem, because of their predominant V H replacements, to originate from a more differentiated BCP. 10, 29 Based on the reported high frequency of IGH oligoclonality by SB in BCP ALL of 30-40%, 32, 33 which exceeds the overall frequency of oligoclonality in this study, we compared the results obtained with PCR and SB methods in HeH leukemias. Although the frequency of monoclonality or oligoclonality based on the two different verification techniques was highly concordant, the accordance rate for individual cases was only moderate. IGH rearrangements exclusively detected by PCR were supposedly derived from minor subclones that are below the detection level of SB rearrangements, rearrangements that were found only by SB may either have been missed by PCR due to the use of consensus primers or the recombination with pseudogenes. 17 Alternatively, irregularly rearranged bands at SB may also result from translocation-associated IGH rearrangements, as have been recently described. 34, 35 Finally, we like to discuss the data with respect to their potential implications for MRD analysis. Based on the pattern of IGH rearrangements in BCP ALL and association with the copy numbers of IGH alleles or chromosomes 14, respectively, monoclonal cases cannot be discriminated from oligoclonal ones without information about the genetic subtype and/or IGH allele or chromosome 14 copy numbers. In the HeH group, about 45% of cases appear oligoclonal at the IGH locus, which accounts for 10-15% of all childhood BCP ALL. Thus, leukemias with an oligoclonal pattern of IGH rearrangements couldFtogether with the true oligoclonal onesFrepresent approximately 25-30%. According to the current recommendations of the European study group for MRD target selectionFthe IGH locus should thus be avoided in this large group of BCP ALL. 36 Because leukemias with DJ H rearrangements generally have also a less immature TCR immunogenotype, 17 IGH rearrangements might remain as the only sensitive targets for MRD in some of these cases. 5 The type of secondary rearrangements that were initially expected to serve as discriminating markers may thus only reflect oligoclonality, because V H replacements prevail in oligoclonal cases, although they are also present in monoclonal-appearing HeH cases with trisomy 14. Hence, the interpretation of whether a particular IGH rearrangement pattern is really oligoclonal or not may be better defined by taking into account at least the genetic subtype of the respective leukemia (that is, hyperdiploid versus those with various fusion genes), an information that should be readily available in the vast majority of treatment studies. If necessary the quality of this information can be further refined by enumerating chromosomes 14 with karyotyping or IGH alleles with interphase FISH.
